Moser Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,452
Closed -$131K 169
2024
Q4
$131K Sell
1,452
-225
-13% -$21.8K 0.07% 81
2024
Q3
$166K Hold
1,677
0.09% 81
2024
Q2
$155K Buy
1,677
+22
+1% +$1.97K 0.08% 81
2024
Q1
$157K Buy
1,655
+25
+2% +$2.32K 0.09% 79
2023
Q4
$146K Sell
1,630
-411
-20% -$30.5K 0.09% 74
2023
Q3
$149K Buy
2,041
+193
+10% +$15.4K 0.1% 71
2023
Q2
$154K Buy
+1,848
New +$155K 0.1% 70
2022
Q4
$127K Buy
1,527
+100
+7% +$8.1K 0.1% 72
2022
Q3
$113K Hold
1,427
0.09% 74
2022
Q2
$106K Hold
1,427
0.08% 75
2022
Q1
$128K Buy
1,427
+782
+121% +$72.2K 0.08% 74
2021
Q4
$72K Buy
645
+100
+18% +$12.1K 0.04% 88
2021
Q3
$69K Buy
545
+493
+948% +$63.5K 0.04% 88
2021
Q2
$7K Buy
+52
New +$6.84K ﹤0.01% 118

Other funds holding XBI

Moser Wealth Advisors's XBI Position: Q1 2025 in Review

Moser Wealth Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 1,452 shares — an estimated $131K sold.

Moser Wealth Advisors first reported a position in XBI in Q2 2021 and held it in 14 quarters. The position peaked at $166K in Q3 2024. 682 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

  • Moser Wealth Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
  • Moser Wealth Advisors sold 1,452 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $131K.
  • Moser Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2021 and held it in 14 quarters.
  • Moser Wealth Advisors's State Street SPDR S&P Biotech ETF position peaked at $166K in Q3 2024.
  • 682 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Moser Wealth Advisors's 13F filing for Q1 2025, filed 22 Apr 2025.